Differences in the treatment patterns of small renal masses: A disaggregated analyses by race/ethnicity

Samuel Carbunaru1, Jordan M Rich1, Yassamin Neshatvar1

  • 1Department of Urology, New York University School of Medicine, New York, NY.

Urologic Oncology
|October 5, 2024
PubMed
Abstract

Insights

Management of small kidney tumors varies significantly across race/ethnic subgroups. Black Non-Hispanic and Mexican patients were more likely to receive surveillance for smaller tumors and radical nephrectomy for larger tumors compared to White patients.

Area of Science:

  • Urology
  • Oncology
  • Health Services Research

Background:

  • Small renal masses (SRMs) are increasingly detected.
  • Management strategies for SRMs include surveillance and radical nephrectomy.
  • Understanding disparities in SRM management is crucial for equitable cancer care.

Purpose of the Study:

  • To investigate variations in the management of small renal masses (SRMs) across disaggregated race/ethnic subgroups.
  • To compare management patterns between specific race/ethnic groups and aggregate National Institute of Health (NIH) categories.

Main Methods:

  • Utilized the National Cancer Database to identify patients with clinically localized kidney cancer and tumor size ≤4cm.
  • Analyzed 16 predefined racial/ethnic subgroups, comparing surveillance use for tumors <2cm and radical nephrectomy use for tumors ≤4cm.
  • Employed multivariable logistic regression to assess the independent association of race/ethnicity with management, adjusting for baseline characteristics.

Main Results:

  • Identified 286,063 patients meeting inclusion criteria.
  • Black Non-Hispanic and Mexican patients were more likely to undergo surveillance for tumors <2cm compared to White patients.
  • Black Non-Hispanic, Filipino, Japanese, Mexican, and Native Indian patients were more likely to undergo radical nephrectomy for tumors ≤4cm compared to White patients.
  • Disaggregated analyses revealed management associations not captured by aggregate NIH race categories.

Conclusions:

  • Significant variations exist in the use of surveillance and radical nephrectomy for SRMs among specific race/ethnic subgroups.
  • A disaggregated approach is essential for identifying nuanced differences in treatment patterns.
  • Further research is warranted to optimize kidney cancer care and address identified disparities across all patient populations.